Transitional cell carcinoma: Cytologic criteria to improve diagnostic accuracy

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 225-232

  Raab, Stephen S ^a   Slagel, Daniel D ^a   Jensen, Chris S ^a   Teague, Mark W ^a   Savell, Van H ^a   Ozkutlu, Dilek ^a   Lenel, Julia C ^a   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Diagnosis; Likelihood ratio; ROC curves; Urinary cytology

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; OBSERVER VARIATION; PATHOLOGY; PROBABILITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; ROC CURVE;

CARCINOMA, TRANSITIONAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; OBSERVER VARIATION; PROBABILITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 0030095626     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cancer Facts and Figures - 1995, p 16. Atlanta, American Cancer Society, 1995.
2. Lynch CF, Cohen MB: Urinary system: Incidence and prognosis by histologic type. SEER population based data, 1973-87. Cancer 75:316, 1995.
3. Raab SS, Lenel JC, Cohen MB: Low-grade transitional cell carcinoma of the bladder: Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 74:1621, 1994.
4. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS: Urinary cytology and bladder cancer: The cellular features of transitional cell neoplasms. Cancer 53:1555, 1984.
5. Murphy WM: Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 21:886, 1990.
6. Murphy WM: Current topics in the pathology of bladder cancer. Pathol Annu 18:1, 1983.
7. Schwalb DM, Herr HW, Fair WR: The management of clinically unconfirmed positive urinary cytology. J Urol 150: 1751, 1993.
8. Koss LG, Deitch D, Ramanathan R, Sherman AB: Diagnostic value of cytology of voided urine. Acta Cytol 29:810, 1985.
9. Umiker W: Accuracy of cytologic diagnosis of cancer of the urinary tract. Symp Diag Accur Cytolog Techn 8:186, 1964.
10. Kern WH: The cytology of transitional cell carcinoma of the urinary bladder. Acta Cytol 19:420, 1975.
11. Murphy WM: Diseases of the urinary bladder, urethra, ureters and renal pelves. In Urological Pathology, edited by Murphy WM, p 34. Philadelphia, Saunders, 1989.
12. Rife CC, Farrow GM, Utz DC: Urine cytology of transitional cell neoplasms. Symp Advan Labor Intraoper Diagn Technique 6:599, 1979.
13. Kern WH: Urinary tract. In Comprehensive Cytopathology, edited by Bibbo M, p 433. Philadelphia, Saunders, 1991.
14. Esposti PL, Zajicek J: Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings: A critical review of 326 tumors. Acta Cytol 16:529, 1972.
15. Shenoy UA, Colby TV, Schumann GB: Reliability of urinary cytodiagnosis in urothelial neoplasms. Cancer 56:2041, 1985.
16. Rife CC, Farrow GM, Utz DC: Urine cytology of transitional cell neoplasms. Urol Clin North Am 6:599, 1979.
17. Mostofi FK, Sorbin LH, Torloni R: Histologic Typing of Urinary Bladder Tumors: International Classification of Tumours 19. Geneva, World Health Organization, 1973.
18. Raab SS, Thomas PA, Lenel JC, et al.: Pathology and probability: Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimens. Am J Clin Pathol 103:588, 1995.
19. Raab SS: Diagnostic accuracy in cytopathology. Diagn Cytopathol 10:68, 1994.
20. Sackett DL, Haynes RB, Guyatt GH, Tugwell P: Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, Little, Brown, 1991.
21. Radack KL, Rouan G, Hedges J: The likelihood ratio: An improved measure for reporting and evaluating diagnostic test results. Arch Pathol Lab Med 110:689, 1986.
22. Giard RW, Hermans J: Interpretation of diagnostic cytology with likelihood ratios. Arch Pathol Lab Med 114:852, 1990.
23. Langley FA, Buckley CH, Taster M: The use of ROC curves in histopathologic decision making. Anal Quant Cytol 7:167, 1985.
24. Dorfman DD, Berbaum KS: RSCORE-J: Pooled rating method data - a computer program for analyzing pooled ROC curves. Behav Res Methods Instrum Comput 18:452, 1986.
25. Dorfman DD: RSCORE II. In Evaluation of Diagnostic Systems: Methods from Signal Detection Theory, edited by Swets JA, Pickett RM. New York, Academic, 1982.
26. Kannan V, Bose S: Low-grade transitional cell carcinoma and instrument artifact: A challenge in urinary cytology. Acta Cytol 37:899, 1993.
27. Sack MJ, Artymyshyn RL, Tomaszewski JE, Gupta PK: Diagnostic value of bladder wash cytology, with special reference to low-grade urothelial neoplasms. Acta Cytol 39:187, 1995.
28. Yazdi HM: Genitourinary cytology. Clin Lab Med 11:369, 1991.
29. Murphy WM: Urinary cytology in diagnostic pathology. Diagn Cytopathol 1:173, 1985.
30. Eagan JW: Urinary tract cytology. In Uropathology, edited by Hill JS, Vol 2. New York, Churchill Livingstone, 1989.
31. DiBonito L, Musse MM, Dudine S, Falconieri G: Cytology of transitional-cell carcinoma of the urinary bladder: Diagnostic yield and histologic basis. Diagn Cytopathol 8:124, 1992.
32. MacFarlane EW: Some pathologic conditions affecting urine cytology. Acta Cytol 7:196, 1963.
33. El-Bolkainy MN: Cytology of bladder carcinoma. J Urol 124: 20, 1980.
34. Badalament RA, Gay H, Cibas ES, et al.: Monitoring endoscopic treatment of superficial bladder carcinoma by post-operative urinary cytology. J Urol 138:760, 1987.
35. Beck JR, Shultz EK: The use of relative operative characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 110:13, 1986.
36. Rainer RO, Geisinger KR: Beyond sensitivity and specificity. Am J Clin Pathol 103:541, 1995.
37. Raab SS, Isacson C, Layfield LJ, et al.: Atypical glandular cells of undetermined significance: Cytologic criteria to separate clinically significant from benign lesions. Am J Clin Pathol 104:574, 1995.
38. Cohen MB, Wittchow RJ, Johlin FC, Bottles K, Raab SS: Brush cytology of the extrahepatic biliary tract: Comparison of cytologic features of adenocarcinoma and benign biliary strictures. Mod Pathol 8:498, 1995.
39. Prentice RL: Use of the logistic model in retrospective studies. Biometrics 32:599, 1976.
40. Bottles K, Reznicek MJ, Holly EA, et al.: Cytologic criteria to diagnose adenocarcinoma in pleural effusion. Mod Pathol 4:677, 1991.
41. Cohen MB, Haber MM, Holly EA, et al.: Cytologic criteria to distinguish hepatocellular carcinoma from non-neoplastic liver. Am J Clin Pathol 95:125, 1991.
42. Cohen MB, Egerter DP, Holly EA, Ahn DK, Miller TR: Pancreatic adenocarcinoma: Regression analysis to identify improved cytologic criteria. Diagn Cytopathol 7:341, 1991.
43. Bottles K, Cohen MB, Holly E, et al.: A step-wise logistic regression analysis of hepatocellular carcinoma: An aspiration biopsy study. Cancer 62:588, 1988.
44. Bottles K, Chan JS, Holly EA, Chiu S-H, Miller TR: Cytologic criteria for fibroadenoma. Am J Clin Pathol 89:707, 1988.
45. Schnitt SJ, Connolly JL, Tavassoli FA, et al.: Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16: 1133, 1992.
46. Cohen MB, Perez-Reyes N, Stoloff AL: The status of residency training in cytopathology. Diagn Cytopathol 12:1986, 1985.